USANA Health Sciences, Inc.USNANYSE

Revenue (LTM)

$925M

+8.3% YoY

Net Income (LTM)

$11M

-74.4% YoY

Free Cash Flow

$9M

Revenue CAGR (5Y)

-6.0%

—Marginsstable

FCF$0.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Jan 26
Revenue	1,186	999↓15.8%	921↓7.8%	855↓7.2%	925↑8.3%
Gross Profit	956	791↓17.2%	732↓7.5%	679↓7.2%	724↑6.7%
Operating Income	170	108↓36.8%	93↓13.5%	66↓28.7%	51↓23.3%
Net Income	117	69↓40.5%	64↓8.0%	42↓34.1%	11↓74.4%
EBITDA	193	130↓32.5%	123↓5.5%	99↓19.7%	91↓8.4%
EPS Diluted	5.73	3.59↓37.3%	3.30↓8.1%	2.19↓33.6%	0.58↓73.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Jan 26
Cash & Equivalents	240	288↑20.3%	330↑14.6%	182↓45.0%	158↓12.9%
Total Current Assets	363	381↑5.1%	418↑9.6%	279↓33.2%	288↑3.3%
Total Assets	578	597↑3.3%	633↑6.1%	748↑18.2%	743↓0.7%
Total Current Liabilities	161	144↓10.5%	119↓17.4%	140↑17.5%	129↓7.9%
Total Liabilities	183	162↓11.2%	136↓16.4%	162↑19.4%	157↓3.2%
Total Equity	395	434↑10.0%	497↑14.4%	532↑7.0%	533↑0.2%
Total Debt	17	14↓20.3%	13↓4.2%	39↑196.9%	14↓64.3%
Net Debt	-223	-275↓23.4%	-317↓15.5%	-143↑55.1%	-144↓1.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Jan 26
Operating Cash Flow	121	104↓14.3%	71↓32.0%	61↓13.7%	22↓63.4%
Capital Expenditure	-13	-10↑18.5%	-14↓39.4%	-10↑30.5%	-14↓37.2%
Free Cash Flow	108	94↓13.8%	56↓40.0%	51↓9.3%	9↓83.3%
Stock-Based Comp	14	13↓5.7%	15↑8.2%	15↓0.3%	14↓5.0%
Net Change in Cash	-72	48↑165.9%	42↓12.0%	-149↓454.8%	-23↑84.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance